TCL Archive Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study December 26, 2014
TCL Archive Rogers Subcommittee Rewrite Cancer Control Definition, Adds $45 Million Over Three Years April 21, 1978
TCL Archive This month’s 8-page Business & Regulatory Report included in this issue. January 30, 2004